InvestorsHub Logo
Followers 28
Posts 1440
Boards Moderated 0
Alias Born 12/18/2014

Re: Extremist223 post# 109520

Thursday, 03/23/2017 11:11:44 AM

Thursday, March 23, 2017 11:11:44 AM

Post# of 705610
Technically yes in regards to combo treatment. But I think another plausible way to look at this is Revimmune has IP (intellectual property or patents) on something Cognate intends to commercialize (they're not infringing or moreover there are no damages worth going to court for until commercialization). I suspect Cognate is simply clearing their path.

When I get some time I intend to look into this further.

I'm here primarily for the pop-up ads I'm just that impulsive.
(Thankfully there are no such ads on the moderator screen)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News